Healthcare provider profile · identity verified

Scott C. Waters, DO

Family Practice · CAVE CREEK, AZ · NPI 1245209741

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	475	168
Lisinopril	Lisinopril	365	122
Amlodipine Besylate	Amlodipine Besylate	327	118
Levothyroxine Sodium	Levothyroxine Sodium	326	108
Losartan Potassium	Losartan Potassium	277	98
Rosuvastatin Calcium	Rosuvastatin Calcium	208	76
Tamsulosin Hcl	Tamsulosin Hcl	187	63
Pantoprazole Sodium	Pantoprazole Sodium	175	71
Metoprolol Succinate	Metoprolol Succinate	151	59
Gabapentin	Gabapentin	129	54
Trazodone Hcl	Trazodone Hcl	129	48
Pravastatin Sodium	Pravastatin Sodium	119	38
Metformin Hcl Er	Metformin Hcl	118	45
Omeprazole	Omeprazole	116	42
Simvastatin	Simvastatin	102	34
Alprazolam	Alprazolam	100	27
Methylprednisolone	Methylprednisolone	96	82
Hydrochlorothiazide	Hydrochlorothiazide	94	33
Allopurinol	Allopurinol	89	29
Eliquis	Apixaban	89	26
Metformin Hcl	Metformin Hcl	87	31
Escitalopram Oxalate	Escitalopram Oxalate	76	27
Meloxicam	Meloxicam	71	34
Zolpidem Tartrate	Zolpidem Tartrate	69	25
Albuterol Sulfate Hfa	Albuterol Sulfate	68	31
Metoprolol Tartrate	Metoprolol Tartrate	68	26
Ezetimibe	Ezetimibe	66	28
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	66	21
Fluticasone Propionate	Fluticasone Propionate	65	28
Lorazepam	Lorazepam	63	16
Sertraline Hcl	Sertraline Hcl	62	22
Azithromycin	Azithromycin	56	49
Carvedilol	Carvedilol	53	17
Amoxicillin	Amoxicillin	52	30
Montelukast Sodium	Montelukast Sodium	50	23
Famotidine	Famotidine	49	19
Finasteride	Finasteride	47	15
Fluoxetine Hcl	Fluoxetine Hcl	46	20
Triamcinolone Acetonide	Triamcinolone Acetonide	44	32
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	41	36
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	41	26
Glipizide	Glipizide	40	14
Doxycycline Monohydrate	Doxycycline Monohydrate	39	30
Mirtazapine	Mirtazapine	39	14
Valacyclovir	Valacyclovir Hcl	39	26
Clonazepam	Clonazepam	36	suppressed
Tizanidine Hcl	Tizanidine Hcl	36	11
Sumatriptan Succinate	Sumatriptan Succinate	35	suppressed
Testosterone Cypionate	Testosterone Cypionate	35	11
Furosemide	Furosemide	34	12
Ipratropium Bromide	Ipratropium Bromide	34	18
Potassium Chloride	Potassium Chloride	34	17
Clopidogrel	Clopidogrel Bisulfate	33	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	16
Ondansetron Hcl	Ondansetron Hcl	33	20
Tramadol Hcl	Tramadol Hcl	33	12
Trulicity	Dulaglutide	33	suppressed
Fenofibrate	Fenofibrate	32	11
Jardiance	Empagliflozin	32	suppressed
Prednisone	Prednisone	32	25
Acyclovir	Acyclovir	30	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	30	suppressed
Ozempic	Semaglutide	29	11
Meclizine Hcl	Meclizine Hcl	28	15
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Atenolol	Atenolol	27	suppressed
Glipizide Er	Glipizide	27	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	26	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	23
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Duloxetine Hcl	Duloxetine Hcl	26	11
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Azelastine Hcl	Azelastine Hcl	25	suppressed
Testosterone	Testosterone	25	suppressed
Valsartan	Valsartan	25	suppressed
Cephalexin	Cephalexin	24	24
Lovastatin	Lovastatin	23	suppressed
Alendronate Sodium	Alendronate Sodium	22	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Ketoconazole	Ketoconazole	21	14
Benazepril Hcl	Benazepril Hcl	20	suppressed
Ibuprofen	Ibuprofen	20	11
Irbesartan	Irbesartan	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	17
Bupropion Xl	Bupropion Hcl	19	suppressed
Lidocaine	Lidocaine	19	suppressed
Telmisartan	Telmisartan	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Mupirocin	Mupirocin	17	16
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Diazepam	Diazepam	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Estradiol	Estradiol	15	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	14	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Levofloxacin	Levofloxacin	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Xigduo Xr	Dapaglifloz Propaned/Metformin	14	suppressed
Fluocinonide	Fluocinonide	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Tobramycin	Tobramycin	13	11
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Cromolyn Sodium	Cromolyn Sodium	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Spironolactone	Spironolactone	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error